Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Homeopathic Treatment of Children and Youth With ADHD
NCT02086864Phase 2Completed
- Sponsor
- University of Toronto
- Start
- Mar 2014
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by University of Toronto. Primary endpoint: Conners 3 Global Index - Parent at 28 weeks. Started Mar 2014; status: completed.
02
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02086864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086864.